Dolby Laboratories Inc (NYSE: DLB) has a price-to-earnings ratio that is above its average at 32.92x. The stock has a 36-month beta value of 0.98. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for DLB is 59.48M, and at present, short sellers hold a 1.35% of that float. On January 30, 2025, the average trading volume of DLB was 468.33K shares.
DLB) stock’s latest price update
The stock price of Dolby Laboratories Inc (NYSE: DLB) has surged by 10.75 when compared to previous closing price of 80.63, but the company has seen a 11.01% gain in its stock price over the last five trading sessions. zacks.com reported 2025-01-30 that DLB’s fiscal first-quarter 2025 performance gains from steady growth in the Licensing, and the Products and services segments.
DLB’s Market Performance
Dolby Laboratories Inc (DLB) has experienced a 11.01% rise in stock performance for the past week, with a 13.79% rise in the past month, and a 22.33% rise in the past quarter. The volatility ratio for the week is 1.87%, and the volatility levels for the past 30 days are at 1.73% for DLB. The simple moving average for the last 20 days is 11.69% for DLB stock, with a simple moving average of 15.94% for the last 200 days.
Analysts’ Opinion of DLB
Many brokerage firms have already submitted their reports for DLB stocks, with Barrington Research repeating the rating for DLB by listing it as a “Outperform.” The predicted price for DLB in the upcoming period, according to Barrington Research is $100 based on the research report published on June 03, 2024 of the previous year 2024.
Rosenblatt gave a rating of “Buy” to DLB, setting the target price at $90 in the report published on May 24th of the previous year.
DLB Trading at 13.05% from the 50-Day Moving Average
After a stumble in the market that brought DLB to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 4.69% of gains for the given period.
Volatility was left at 1.73%, however, over the last 30 days, the volatility rate increased by 1.87%, as shares surge +13.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.50% upper at present.
During the last 5 trading sessions, DLB rose by +10.52%, which changed the moving average for the period of 200-days by +10.86% in comparison to the 20-day moving average, which settled at $79.93. In addition, Dolby Laboratories Inc saw 14.34% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DLB starting from SHERMAN MARK ANDREW, who sale 12,338 shares at the price of $78.08 back on Dec 17 ’24. After this action, SHERMAN MARK ANDREW now owns 62,397 shares of Dolby Laboratories Inc, valued at $963,303 using the latest closing price.
MARK A SHERMAN, the Officer of Dolby Laboratories Inc, proposed sale 12,338 shares at $78.08 during a trade that took place back on Dec 17 ’24, which means that MARK A SHERMAN is holding shares at $963,303 based on the most recent closing price.
Stock Fundamentals for DLB
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.89 for the gross margin
The net margin for Dolby Laboratories Inc stands at 0.21. The total capital return value is set at 0.1. Equity return is now at value 10.82, with 8.62 for asset returns.
Based on Dolby Laboratories Inc (DLB), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 6.96.
Currently, EBITDA for the company is 258.33 million with net debt to EBITDA at -1.55. When we switch over and look at the enterprise to sales, we see a ratio of 6.26. The receivables turnover for the company is 2.48for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.91.
Conclusion
To sum up, Dolby Laboratories Inc (DLB) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
